Anti-PCI monoclonal antibody

Details Anti-PCI monoclonal antibody Anti-PCI monoclonal antibody

1987-11-05

1993-03-09

Kepplinger, Esther L.

Chemistry: analytical and immunological testing

Involving production or treatment of antibody

Monoclonal antibody

436808, 53038825, 5303881, 530413, 43524027, G01N 33577, C12P 2108, C12N 520

Patent

active

051926946

ABSTRACT:
A monoclonal antibody specific to a human placenta-derived coagulation inhibitor is disclosed. The antibody is produced by culturing a hybridoma which secretes it. A human placenta-derived coagulation inhibitor can be purified by using the monoclonal antibody as an immunoadsorbent. The human placenta-derived coagulation inhibitor can be immunologically assayed by using the monoclonal antibodies.

REFERENCES:
patent: 4486530 (1984-12-01), David et al.
patent: 4552760 (1985-11-01), Murakami et al.
patent: 4568544 (1986-02-01), Hasegawa et al.
patent: 4732891 (1988-03-01), Maki et al.
patent: 4736018 (1988-04-01), Reutelingsperger
patent: 4751084 (1988-06-01), Feder et al.
Reutelingsperger et al., European Journal of Biochemistry, vol. 151, pp. 625-629 (1985).

Affiliated with

Also associated with

Rating

Anti-PCI monoclonal antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-PCI monoclonal antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-PCI monoclonal antibody will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-210991